Skip to content

People
Capabilities
Main /
Capabilities
Capabilities

Antitrust

Artificial Intelligence

Business Restructuring

Corporate & Transactional

Crisis Management

Data, Privacy & Cybersecurity

Employee Benefits & Executive Compensation

Employment

Government & Lobbying Strategies

Government Contracts

Intellectual Property

International Trade

Investment Management

Litigation & Dispute Resolution

Mergers & Acquisitions

Private Client

Real Estate

Shareholder Activism

Strategic Solutions

Sustainability, Impact & ESG

Tax

Trade Secrets

White-Collar Defense & Government Investigations

Regional Markets

View all capabilities
Industries spotlight

Health & Life Sciences

Guiding health and life sciences transformation

Private Equity

Driving investment performance

Media, Entertainment & Sports

Turning creative assets into strategic value

View all
Industries
Main /
Industries
Industries

Accounting & Consulting Services

Alcohol

Digital Infrastructure

Energy & Infrastructure

Financial Services

FinTech & Blockchain

Food, Beverage & Agribusiness

Health & Life Sciences

Insurance

Media, Entertainment & Sports

Private Equity

Technology

Venture Capital & Emerging Growth

View all industries
Case studies

Zocdoc

How Zocdoc broke regulatory ground as an online healthcare resource

Doral Renewables

Doral Renewables’ drive to build sustainable solar solutions

Sustainable Procurement Pledge

Connecting the dots for supply chain sustainability

View all case studies
Insights
main /
Insights
Featured

main / Insights / Featured

Health & Life Sciences

Where MedTech is attracting PE attention with less FDA burden

White-Collar Defense

DOJ revises Justice Manual guidance on two key False Claims Act issues

Energy & Infrastructure

What the Copia Power sale signals for digital infrastructure investment

Topics

main / Insights / Topics

Private Capital

Global Privacy & Cybersecurity

Artificial Intelligence Law

US Policy Watch

View all insights
Categories

main / Insights / Categories

Articles

Client Alerts

Case Studies

Podcasts

Reports

Resources

Topics

Videos

Trending

main / Insights / Trending

Client alert DEA appears close to finalizing telemedicine special registration

Client alert 24-hour reporting deadline under the EU Cyber Resilience Act now in effect
- Articles
- Client Alerts
- Case Studies
- Podcasts
- Reports
- Resources
- Topics
- Videos
Events
Main /
Events
Upcoming events

Oct 19 – Oct 23

In-person Pepperdine’s Global Family Office Summit 2026

October 27, 2026

In-person San Francisco Private Funds Roundtable & Cocktail Reception

Oct 29

Virtual 340B: Back to Basics

Oct 22

Virtual Canary Forum 2026

Oct 27

Virtual Cybersecurity Risks in the Workforce: Emerging Threats and Employer Response

Nov 3

Virtual Managing Legal Risk in AI-Driven Employment Decisions

View all events
Featured

In-person

Life Sciences Investment Forum 2026

In-person

HPE Miami 2027
Careers

- English
- Deutsch
- Français
- Italiano

See all results for >

Newsroom Categories: Coverage

Hospitals in Texas and Other States Sue HHS Over DSH Calculation Changes that Impact 340B Eligibility

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Hospitals in Texas and Other States Sue HHS Over DSH Calculation Changes that Impact 340B Eligibility

July 2, 2024

Read time: 2 min

About Us

Related people

Emily Jane Cook

Partner

Los Angeles, Washington, DC

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 2, 2024
RFR Holding’s $560 Million Sale of 980 Madison Avenue in New York

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

RFR Holding’s $560 Million Sale of 980 Madison Avenue in New York

June 27, 2024

Read time: 2 min

About Us

Related people

Elias Eliopoulos

Partner

New York – One Vanderbilt Avenue

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Corporate & Transactional Real Estate United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024
2024 Notable LGBTQIA+ Leaders

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

2024 Notable LGBTQIA+ Leaders

June 26, 2024

Read time: 2 min

About Us

Related people

Edward B. Diskant

Partner

New York – One Vanderbilt Avenue

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Litigation & Dispute Resolution United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024
Feds’ 5th Circ. Win on Preventive Care May Imperil ACA

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Feds’ 5th Circ. Win on Preventive Care May Imperil ACA

June 26, 2024

Read time: 2 min

About Us

Related people

Sarah G. Raaii

Partner

Chicago

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Employee Benefits & Executive Compensation United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024
State Data Privacy Law Patchwork: Midyear Report

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

State Data Privacy Law Patchwork: Midyear Report

June 26, 2024

Read time: 2 min

About Us

Related people

David P. Saunders

Partner

Chicago

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Data, Privacy & Cybersecurity United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024
The Legal Landscape of AI and Digital Health Innovation

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

The Legal Landscape of AI and Digital Health Innovation

June 23, 2024

Read time: 2 min

About Us

Related people

Jennifer S. Geetter

Partner

Washington, DC

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024
340B Drug Program Discounts Protected Under New State Laws

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

340B Drug Program Discounts Protected Under New State Laws

June 25, 2024

Read time: 2 min

About Us

Related people

Emily Jane Cook

Partner

Los Angeles, Washington, DC

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024
So, You Want to Launch in the U.S.? An Overview for Guide to Israeli Health Companies Entering the U.S. Market.

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

So, You Want to Launch in the U.S.? An Overview for Guide to Israeli Health Companies Entering the U.S. Market.

June 13, 2024

Read time: 2 min

About Us

Related people

Jennifer S. Geetter

Partner

Washington, DC

Reuben Bank

Associate

Los Angeles

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Deal announcement

McDermott Will & Schulte advises American Oncology Network on agreement to be acquired by Cencora

Related

Health & Life Sciences United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024
IRS Rulemaking Authority on Shaky Ground with Chevron Overturned

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

IRS Rulemaking Authority on Shaky Ground with Chevron Overturned

July 1, 2024

Read time: 2 min

About Us

Related people

David G. Noren

Partner

Washington, DC

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Client alert

Latest tax updates: Investment fund scrutiny, digital-asset staking, and IRS-DOJ authority

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Tax United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024
Tax Incentives and the Foreign Tax Credit in a Pillar 2 World

Newsroom /

Email LinkedIn Xing Facebook X (Twitter)

Email LinkedIn Xing Facebook X (Twitter)

COVERAGE

Tax Incentives and the Foreign Tax Credit in a Pillar 2 World

June 22, 2024

Read time: 2 min

About Us

Related people

Brian H. Jenn

Partner

Washington, DC, Chicago

You may also like

Coverage

The Deal covers McDermott’s role in American Oncology Network’s proposed acquisition by Cencora

Client alert

Latest tax updates: Investment fund scrutiny, digital-asset staking, and IRS-DOJ authority

Coverage

Kyle Faget discusses prediction market risks in pharmaceutical vendor contracts with Pharmaceutical Executive

Related

Tax United States

Back to top

Media Contact

publicrelations@mcdermottlaw.com

July 1, 2024

←Previous Page

1 … 109 110 111 112 113 … 349

Firm

About
Offices
Newsroom
Alumni
Careers

Sign In

McDermott Access

Related Sites

Farragut Square Group

Connect

Contact
Subscribe

ALWAYS BETTER

Legal Notices/Imprint
Privacy Policy
Terms of Use
Sitemap

Attorney advertising © 2026 McDermott Will & Schulte

Disclaimer

Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott Will & Schulte via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott Will & Schulte from representing any other person or firm in any matter; and will not obligate McDermott Will & Schulte to keep confidential the information you provide. McDermott Will & Schulte cannot enter into an attorney-client relationship with you until McDermott Will & Schulte has determined that doing so will not create a conflict of interest and until you and McDermott Will & Schulte have entered into a written agreement or engagement letter that sets forth the terms of our relationship.